Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Diabetologia ; 51(10): 1862-72, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18663428

ABSTRACT

AIMS/HYPOTHESIS: Recovery from diabetes requires restoration of beta cell mass. Igf1 expression in beta cells of transgenic mice regenerates the endocrine pancreas during type 1 diabetes. However, the IGF-I-mediated mechanism(s) restoring beta cell mass are not fully understood. Here, we examined the contribution of pre-existing beta cell proliferation and transdifferentiation of progenitor cells from bone marrow in IGF-I-induced islet regeneration. METHODS: Streptozotocin (STZ)-treated Igf1-expressing transgenic mice transplanted with green fluorescent protein (GFP)-expressing bone marrow cells were used. Bone marrow cell transdifferentiation and beta cell replication were measured by GFP/insulin and by the antigen identified by monoclonal antibody Ki67/insulin immunostaining of pancreatic sections respectively. Key cell cycle proteins were measured by western blot, quantitative RT-PCR and immunohistochemistry. RESULTS: Despite elevated IGF-I production, recruitment and differentiation of bone marrow cells to beta cells was not increased either in healthy or STZ-treated transgenic mice. In contrast, after STZ treatment, IGF-I overproduction decreased beta cell apoptosis and increased beta cell replication by modulating key cell cycle proteins. Decreased nuclear levels of cyclin-dependent kinase inhibitor 1B (p27) and increased nuclear localisation of cyclin-dependent kinase (CDK)-4 were consistent with increased beta cell proliferation. However, islet expression of cyclin D1 increased only after STZ treatment. In contrast, higher levels of cyclin-dependent kinase inhibitor 1A (p21) were detected in islets from non-STZ-treated transgenic mice. CONCLUSIONS/INTERPRETATION: These findings indicate that IGF-I modulates cell cycle proteins and increases replication of pre-existing beta cells after damage. Therefore, our study suggests that local production of IGF-I may be a safe approach to regenerate endocrine pancreas to reverse diabetes.


Subject(s)
Cell Cycle Proteins/metabolism , Insulin-Like Growth Factor I/metabolism , Insulin-Secreting Cells/metabolism , Islets of Langerhans/metabolism , Animals , Apoptosis/drug effects , Blood Glucose/metabolism , Blotting, Western , Bone Marrow Cells/cytology , Bone Marrow Cells/metabolism , Bone Marrow Transplantation/methods , Cell Cycle/drug effects , Cell Cycle Proteins/genetics , Cell Division/drug effects , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Immunohistochemistry , Insulin-Like Growth Factor I/genetics , Insulin-Secreting Cells/cytology , Insulin-Secreting Cells/drug effects , Islets of Langerhans/cytology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Reverse Transcriptase Polymerase Chain Reaction , Streptozocin/pharmacology
2.
Immunity ; 14(5): 591-602, 2001 May.
Article in English | MEDLINE | ID: mdl-11371361

ABSTRACT

In this study, we have compared the effector functions and fate of a number of human CTL clones in vitro or ex vivo following contact with variant peptides presented either on the cell surface or in a soluble multimeric format. In the presence of CD8 coreceptor binding, there is a good correlation between TCR signaling, killing of the targets, and FasL-mediated CTL apoptosis. Blocking CD8 binding using alpha3 domain mutants of MHC class I results in much reduced signaling and reduced killing of the targets. Surprisingly, however, FasL expression is induced to a similar degree on these CTLs, and apoptosis of CTL is unaffected. The ability to divorce these events may allow the deletion of antigen-specific and pathological CTL populations without the deleterious effects induced by full CTL activation.


Subject(s)
Apoptosis/immunology , HLA-A2 Antigen/immunology , HLA-B Antigens/immunology , Lymphocyte Activation/immunology , Peptides/immunology , T-Lymphocytes, Cytotoxic/immunology , Viral Proteins , CD8-Positive T-Lymphocytes/immunology , Fas Ligand Protein , Gene Products, gag/genetics , Gene Products, gag/immunology , HIV Antigens/genetics , HIV Antigens/immunology , HLA-A2 Antigen/genetics , HLA-B Antigens/genetics , HLA-B44 Antigen , Humans , Influenza A virus/genetics , Influenza A virus/immunology , Membrane Glycoproteins/immunology , Membrane Proteins/immunology , Mutagenesis , Peptide Fragments/genetics , Peptide Fragments/immunology , Phosphorylation , Receptors, Antigen, T-Cell/immunology , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Viral Matrix Proteins/genetics , Viral Matrix Proteins/immunology , beta 2-Microglobulin/genetics , beta 2-Microglobulin/immunology , fas Receptor/immunology , gag Gene Products, Human Immunodeficiency Virus
3.
Eur J Immunol ; 31(2): 440-9, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11180108

ABSTRACT

Engineered MHC-peptide targets capable of inducing recognition by CTL may prove useful in designing vaccines for infectious disease and cancer. We tested whether peptides directly linked to beta2-microglobulin (beta2m) could complex with human HLA class I heavy chain, and could be recognized by human CTL, both as soluble reagents and as cell surface constituents. An HLA-A2-restricted peptide epitope was physically linked to the N terminus of human beta2m. This fusion protein refolded efficiently in vitro with HLA-A2 heavy chain, and when multimerized, the resultant complexes ("fusamers") bound specifically to appropriate CTL clones. These fused peptide/MHC complexes were as efficient as standard tetrameric peptide/MHC complexes in recognizing antigen-specific CTL. When the fusion protein was delivered to target cells using a retroviral vector, these cells were recognized and killed by appropriate CTL clones. Efficient sensitization to CTL lysis was achieved in TAP-negative and beta2m-negative cell lines, as well as in unmutated B cell lines, proving that such constructs may be effective in inducing CTL even when the MHC class I pathway has been disrupted. Specific peptides covalently linked to beta2m and delivered via retroviral vectors may be useful reagents for in vivo priming of CTL against epitopes of clinical relevance.


Subject(s)
Antigen Presentation , Histocompatibility Antigens Class I/physiology , Neoplasms/therapy , Recombinant Fusion Proteins/immunology , T-Lymphocytes, Cytotoxic/immunology , beta 2-Microglobulin/immunology , Cell Line , Cytotoxicity, Immunologic , Genetic Therapy , Histocompatibility Antigens Class I/chemistry , Humans , Neoplasms/immunology , Retroviridae/genetics , beta 2-Microglobulin/genetics
4.
J Exp Med ; 192(9): 1317-26, 2000 Nov 06.
Article in English | MEDLINE | ID: mdl-11067880

ABSTRACT

The effect of infection history is ignored in most animal models of infectious disease. The attachment protein of respiratory syncytial virus (RSV) induces T helper cell type 2-driven pulmonary eosinophilia in mice similar to that seen in the failed infant vaccinations in the 1960s. We show that previous influenza virus infection of mice: (a) protects against weight loss, illness, and lung eosinophilia; (b) attenuates recruitment of inflammatory cells; and (c) reduces cytokine secretion caused by RSV attachment protein without affecting RSV clearance. This protective effect can be transferred via influenza-immune splenocytes to naive mice and is long lived. Previous immunity to lung infection clearly plays an important and underestimated role in subsequent vaccination and infection. The data have important implications for the timing of vaccinations in certain patient groups, and may contribute to variability in disease susceptibility observed in humans.


Subject(s)
Lung/immunology , Lung/virology , Orthomyxoviridae Infections/immunology , Respiratory Syncytial Virus Infections/prevention & control , Respiratory Syncytial Virus Infections/virology , Respiratory Syncytial Virus, Human/physiology , Animals , Antibodies, Viral/immunology , Antigens, Viral/immunology , CD8-Positive T-Lymphocytes/cytology , CD8-Positive T-Lymphocytes/immunology , Cell Transplantation , Cytokines/metabolism , Cytotoxicity, Immunologic/immunology , Disease Models, Animal , Disease Susceptibility/immunology , Eosinophilia/complications , Eosinophilia/immunology , Eosinophilia/pathology , Eosinophilia/virology , Female , HN Protein/immunology , Histocytochemistry , Lung/pathology , Lung/physiopathology , Mice , Mice, Inbred BALB C , Orthomyxoviridae/immunology , Orthomyxoviridae/physiology , Orthomyxoviridae Infections/complications , Orthomyxoviridae Infections/pathology , Orthomyxoviridae Infections/virology , Respiratory Syncytial Virus Infections/complications , Respiratory Syncytial Virus Infections/immunology , Respiratory Syncytial Virus, Human/immunology , Respiratory Syncytial Virus, Human/pathogenicity , Spleen/cytology , Spleen/immunology , Superinfection/immunology , Superinfection/pathology , Superinfection/physiopathology , Superinfection/virology , Viral Envelope Proteins , Virus Replication
5.
Nature ; 406(6797): 739-42, 2000 Aug 17.
Article in English | MEDLINE | ID: mdl-10963600

ABSTRACT

For unknown reasons, autoimmune diseases such as type 1 diabetes develop after prolonged periods of inflammation of mononuclear cells in target tissues. Here we show that progression of pancreatic islet inflammation to overt diabetes in nonobese diabetic (NOD) mice is driven by the 'avidity maturation' of a prevailing, pancreatic beta-cell-specific T-lymphocyte population carrying the CD8 antigen. This T-lymphocyte population recognizes two related peptides (NRP and NRP-A7) in the context of H-2Kd class I molecules of the major histocompatibility complex (MHC). As pre-diabetic NOD mice age, their islet-associated CD8+ T lymphocytes contain increasing numbers of NRP-A7-reactive cells, and these cells bind NRP-A7/H-2Kd tetramers with increased specificity, increased avidity and longer half-lives. Repeated treatment of pre-diabetic NOD mice with soluble NRP-A7 peptide blunts the avidity maturation of the NRP-A7-reactive CD8+ T-cell population by selectively deleting those clonotypes expressing T-cell receptors with the highest affinity and lowest dissociation rates for peptide-MHC binding. This inhibits the local production of T cells that are cytotoxic to beta cells, and halts the progression from severe insulitis to diabetes. We conclude that avidity maturation of pathogenic T-cell populations may be the key event in the progression of benign inflammation to overt disease in autoimmunity.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , Diabetes Mellitus, Type 1/immunology , T-Lymphocyte Subsets/immunology , Animals , Autoimmunity , Female , Histocompatibility Antigens Class I/immunology , Islets of Langerhans/immunology , Leukopoiesis , Mice , Mice, Inbred NOD , Mice, Transgenic , T-Lymphocytes, Cytotoxic/immunology
6.
Gene Ther ; 7(2): 153-66, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10673720

ABSTRACT

We have comparatively evaluated the efficiency of a series of retroviral vectors transducing the gp91-phox gene, whose defects are responsible for impaired production of superoxide anion (O2-) by phagocytic cells and lead to the X-linked form of chronic granulomatous disease (X-CGD). These vectors included four constructs based on the MoMuLV backbone and expressing gp91-phox from the viral long terminal repeat (LTR) or from internal promoters, and one construct based on the myelotropic FMEV vector. Expression of the therapeutic gene from the MoMuLV LTR was unsatisfactory after transduction of the PLB985 X-CGD knockout cell line and of primary CD34+ hematopoietic progenitors from X-CGD patients. The presence of either constitutive or inducible internal promoters did not result in important improvements in the efficiency of O2- production and lowered the titers of the viral preparations. In contrast, sustained levels of superoxide generation were obtained upon transduction with the FMEV vector. To analyze the efficiency of transgene expression at the single cell level, over 150 cellular clones were generated from bulk cultures of PLB985 X-CGD cells transduced with this vector, each one representative of an individual transduction event. These clones revealed a markedly heterogeneous pattern of gp91-phox expression, ranging from complete silencing to full restoration of superoxide production. Within each clone, expression of the therapeutic gene correlated with the number of expressing cells rather than with the average levels of expression from each cell, indicating that at the single cell level, the proviral promoter is regulated by a binary, on/off mechanism. Moreover, both transduced bulk and clonal cell populations displayed a tendency to a progressive extinction of expression over time, with a mechanism involving LTR methylation. The design of novel retroviral vectors escaping silencing is highly desirable for efficient gene therapy.


Subject(s)
Genetic Vectors/genetics , Granulomatous Disease, Chronic/genetics , Retroviridae/genetics , Gene Expression , Gene Transfer Techniques , Granulomatous Disease, Chronic/enzymology , Granulomatous Disease, Chronic/virology , HL-60 Cells , HeLa Cells , Humans , NADPH Oxidases/metabolism , Proviruses/genetics , Transgenes/genetics
7.
Ann Ist Super Sanita ; 34(4): 447-55, 1998.
Article in English | MEDLINE | ID: mdl-10234875

ABSTRACT

Chronic granulomatous disease (CGD) is an inherited immunodeficiency characterized by severe recurrent bacterial and fungal infections of several organs. The disease is due to the inability of phagocytic leukocytes to generate reactive oxygen species upon phagocytosis. The defect arises as a consequence of mutations of the genes encoding for the subunits of a membrane NADPH oxidase, which catalyzes the production of superoxide anion (O2-). CGD represents an ideal candidate disorder for gene therapy, since the disease has a recessive inheritance, its phenotype is exclusively expressed in phagocytic cells, and a partial correction is likely to be effective. Given the short half-life of mature phagocytes, the optimal target cell population for gene transfer is the pluripotent hematopoietic stem cell. Transduction of CD34+ hematopoietic progenitors with retroviral vectors carrying the cDNA of the defective gene results in the correction of the enzymatic defect in myeloid cells differentiated in vitro. Still, the effective development of a clinical gene therapy protocol for this disease will await a substantial improvement in our current technology for the identification and manipulation of hematopoietic stem cells, and in our understanding of their biological and molecular properties.


Subject(s)
Genetic Therapy , Granulomatous Disease, Chronic/therapy , Adenoviridae , Antigens, CD34 , Gene Transfer Techniques , Genetic Vectors , Granulomatous Disease, Chronic/genetics , Hematopoietic Stem Cells , Humans , NADPH Oxidases/genetics , Retroviridae , Transduction, Genetic
8.
Gene Ther ; 3(8): 679-84, 1996 Aug.
Article in English | MEDLINE | ID: mdl-8854093

ABSTRACT

A quantitative polymerase chain reaction (PCR) procedure has been developed for rapid retrovirus titration. This procedure, which is based on the simultaneous amplification of the sample with known amounts of a competitor DNA fragment (competitive PCR), was used for the quantification of viral RNA genomes in retrovirus-producing cell clone supernatants and of proviral DNA molecules formed at 24 h after infection of different reference cell lines. The results obtained from the analysis of several samples indicated that proviral DNA quantification is in complete agreement with the number of selectable colonies in a standard colony assay. Conversely, the number of viral RNA genomes in the producer cell clone supernatants is a poor predictor of the actual efficiency of infection. Repeated competitive PCR experiments for provirus copy number determination at different times after transduction indicated that the number of proviral DNA molecules remains stable over time, suggesting stable integration into the host genome. The developed procedure is rapid and simple, is applicable to retroviral constructs not containing a selectable gene and can be used to directly measure the efficiency of infection of any target cell type, thus overcoming the problem of the dependency of retroviral titer determination on the rate of expression of a selectable gene and on the efficiency of colony formation of a reference cell line.


Subject(s)
Genetic Vectors/isolation & purification , Polymerase Chain Reaction/methods , Retroviridae/isolation & purification , 3T3 Cells , Animals , Binding, Competitive , DNA, Viral/metabolism , Genetic Vectors/genetics , HeLa Cells , Humans , Mice , Proviruses/genetics , Retroviridae/genetics , Titrimetry/methods
9.
Exp Cell Res ; 225(2): 257-67, 1996 Jun 15.
Article in English | MEDLINE | ID: mdl-8660913

ABSTRACT

The feasibility of correction of the disease phenotype by gene gene transfer was investigated in cells of four patients with X-linked chronic granulomatous disease. These patients carry point mutations of the gp91-phox gene, encoding for the large subunit of the catalytic core of the phagocytic cell NADPH oxidase. A retroviral vector expressing the gp91-phox protein was constructed and used to transduce lymphoblastoid cell lines established from the patients. Several transduced lymphoblastoid cell clones were investigated for mRNA and protein expression, and for functional reconstitution of oxidase activity. Although extensive quantitative variability was detected among different clones, functional reconstitution of O2- production was obtained in most cases, with oxidase function within the same range as in B cell lines derived from normal individuals. The same vector was also used for transduction of hematopoietic precursors from bone marrow or peripheral blood either with or without enrichment for CD34+ cells. A comprehensive analysis was performed on differentiated myeloid colonies, to evaluate the efficiency of transduction, the levels of gp91-phox expression, and the extent of functional reconstitution of oxidase activity. A high efficiency of transduction was obtained in most experiments, with 60-100% of colonies containing proviral DNA. Among the transduced colonies, an extensive variability in the levels of expression of the transduced gene and of functional restoration of NADPH oxidase activity was observed. These results represent a step toward the development of a gene therapy protocol for these patients.


Subject(s)
Gene Transfer Techniques , Genetic Vectors/physiology , Granulomatous Disease, Chronic/genetics , NADH, NADPH Oxidoreductases/metabolism , Retroviridae/genetics , 3T3 Cells/enzymology , 3T3 Cells/physiology , Animals , B-Lymphocytes/cytology , B-Lymphocytes/physiology , Base Sequence , Callithrix , Cell Line/enzymology , Cell Line/physiology , Granulomatous Disease, Chronic/enzymology , Hematopoiesis/genetics , Hematopoietic Stem Cells/physiology , Humans , Membrane Glycoproteins/genetics , Membrane Glycoproteins/metabolism , Mice , Molecular Sequence Data , NADPH Oxidase 2 , NADPH Oxidases , Nitroblue Tetrazolium , Polymerase Chain Reaction , Transduction, Genetic
SELECTION OF CITATIONS
SEARCH DETAIL
...